An editable, fully cited investment memorandum with a stated view and bull, base and bear scenarios. A working draft to make your own, not a recommendation, with every figure traced to its filing.
Real, cited ABI Nexa output. Use the arrows or dots to move through.
Working material, not a recommendation. ABI Nexa research, from company filings.
| Measure | Value |
|---|---|
| Price / earnings | 68.5x |
| EV / EBITDA | 39.6x |
| EV / Sales | 4.0x |
| Price / book | 5.9x |
| Cost of equity | 9.6% |
Bull case cited to the Q2 2026 earnings release, accession 0001104657-26-000042. Working material, not a recommendation.
From mid-single-digit-plus (12 Feb 2026) to low double-digit growth. Adjusted EPS guide $6.00 to $6.50 affirmed with a tilt to the upper end. The CFO flagged a 15% to 20% EPS step-up next quarter, with more meaningful step-ups in the back half.
Backlog at an all-time high, up 20%+ YoY and 15% year to date. Q1'26 defense bookings $60M, a record first quarter; trailing A&D order rates up 50%. Management cited $300 million-plus open RFQs against $200M at the Q4'25 call.
EM Q1'26 adjusted EBITDA margin hit a record 28.3% on $91.6M of value-added, up 18% YoY. High-performance memory and data-storage sales up 47% YoY; semiconductor value-added $79.5M, total semi orders up 16% YoY and 40% ex-China.
A major U.S. defense prime is funding a $65M expansion of beryllium production across two facilities, completing Q4'27 and enabling sustained double-digit precision-materials growth from 2028. The mid-2025 Korea Konasol acquisition qualifies in the second half of 2026.
Shares rallied from $185.89 pre-print (24 Apr) to $220.75 (5 Jun), a +18.7% move; one-year total return +165% from $83.19.
Cited to the Q2 2026 earnings release and call. ABI Nexa research.
| End market | Q1'26 VA | % of VA | 2026 direction |
|---|---|---|---|
| Semiconductors, incl. AI infra | 79.5 | 30% | Mid/high single-digit+ |
| Aerospace & Defense | 52.5 | 20% | Mid/high single-digit |
| Industrial | 36.7 | 14% | Low single-digit |
| Energy, incl. new energy | 31.4 | 12% | Mid single-digit |
| Life Sciences | 26.2 | 10% | Low/mid single-digit |
| Consumer Electronics | 23.5 | 9% | Low single-digit |
| Automotive | 11.7 | 5% | Below zero |
| Total value-added | 261.8 | 100% | Net mid/high single-digit+ |
| Theme | 2Q23 | 3Q23 | 4Q23 | 1Q24 | 2Q24 | 3Q24 | 4Q24 | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Defense / Aerospace | ||||||||||||
| Semiconductor / AI | ||||||||||||
| Beryllium positioning | ||||||||||||
| Precision Clad Strip / PMI | ||||||||||||
| Margins / profitability | ||||||||||||
| Backlog / order book | ||||||||||||
| M&A / capital allocation | ||||||||||||
| Macro / end-market headwinds |
Derived from twelve quarters of earnings-call transcripts. ABI Nexa research.
A fair value against spot with the gap named, so the memo opens with a position, not a hedge.
The multiples and cost of equity the current price implies, so you argue against what is priced in.
Both sides of the debate written from the filings, so the memo is balanced rather than one-sided.
The events that move the name and what to read from each, on a timeline.
Where revenue actually comes from, so the thesis rests on the real demand drivers.
One click from any number in the memo to the filing it came from.
A cited draft with a stated view, a base-case fair value and a scenario range, ready for your judgement.
0 wrong numbers on the audited sampleEvery finding ties back to the filing or transcript behind it, so you can defend the memo line by line.
cited to the sourceThe scenarios and probability weights are laid out precisely so you can disagree with them and change them.
weights shown, not hiddenTell us the names and markets you follow and we will show you the desk on them.